In a world where the immune system can be both hero and villain, three scientists have illuminated the path to taming its excesses. On October 6, 2025, ...
For the first time, scientists have answered a longstanding question in cell biology about a partnership of proteins called the "KICSTOR–GATOR1 ...
For the first time, scientists have answered a longstanding question in cell biology about a partnership of proteins called ...
A giant functional atlas of immune cells in a Chinese cohort reveals crucial differences with European and Japanese data sets ...
The therapy, A2B543, will be added as an arm to the ongoing Phase I/II EVEREST-2 trial, which is testing CAR T-cell products developed using A2's Tmod platform. According to A2, the Tmod platform ...
Microbes often display cooperative behavior in which individual cells put in work and sacrifice resources to collectively ...
CS-101 is Shanghai-based CorrectSequence's lead candidate, which it is developing for treating sickle-cell disease and ...
One of North America’s most endangered species is getting a new lease on life thanks to technological innovations. This past ...
Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.
Flexoelectricity, which can transform mechanical deformation into electrical signals, could provide enough power to fire ...
Scientists are uncovering why Brazil may be one of the most important yet underused resources for studying extreme longevity.
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results